91AV原创

Tag - eli-lilly

 
91AV原创
Search
 
October 28, 2026
 

Home Delivery
Subscribe for more access

ELI LILLY

People walk past billboards from Innovent Biologics and Meituan displayed on a wall in a metro station in Shanghai on July 6.
BUSINESS / Companies
Aug 24, 2026
Snoring, subways and stealth ads: How big pharma targets China’s waistline
Local restrictions prevent drug companies from directly advertising prescription medicines in the world’s second-largest drug market.
Novo Nordisk is getting a boost from its new Wegovy weight-loss pill.
BUSINESS
Aug 3, 2026
Obesity battle heats up again as Novo claws its way back into race with Lilly
Novo Nordisk is getting a boost from its new Wegovy weight-loss pill that ?is holding onto its lead against Eli Lilly’s more recently launched Foundayo.
A surgeon fills a syringe with Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss.
JAPAN / Science & Health / EXPLAINER
Jun 10, 2026
‘Thinness equals beauty’: Mounjaro misuse among women sparks health debate in Japan
The nation is one of the leanest in the world, making the misuse of the diabetes drug simply for weight loss that much more alarming.
A partly-used, 10 gram bag of semaglutide powder made by China-based Sinopep-Allsino Biopharmaceutical, at a compounding pharmacy in Arlington, Virginia, in December 2024.
BUSINESS / Companies
Sep 3, 2025
Chinese companies turn to generics as patents expire on weight-loss drugs
U.S. regulators have restricted the sale of cheap copies of the drugs, slowing demand for raw ingredients Chinese firms supplied over the past two years.
Shares of Eli Lilly & Co. surged on the New York Stock Exchange on Thursday after early reports of its experimental weight-loss drug put in a par with market leader Ozempic. The stocks of the drug’s originator, Chugai Pharmaceutical Co., also saw an uptick.
BUSINESS / Companies
Apr 18, 2025
Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai
Eli Lilly’s orforglipron pill, licensed from Chugai Pharmaceutical, could reshape the booming weight-loss drug market, early data shows.
A scientist looks at brain scans of a patient suffering from Alzheimer's disease in Geneva in 2023.
WORLD / Science & Health
Sep 21, 2024
Revolution or mirage? Controversy surrounds new Alzheimer’s drugs
For defenders, the drugs represent a real chance to fight the disease. For detractors, they are a disappointment after a long line of costly failures.
A health ministry panel has approved Eli Lilly's donanemab drug for Alzheimer's patients.
JAPAN / Science & Health
Aug 2, 2024
91AV原创 health ministry set to approve second Alzheimer’s drug
Donanemab, developed by U.S. pharmaceutical firm Eli Lilly, has been backed by a ministry panel.
Alphabet CFO Ruth Porat
BUSINESS / Companies
Jun 6, 2024
Alphabet taps Eli Lilly executive as new CFO replacing Porat
Anat Ashkenazi will replace Ruth Porat who announced last year she planned to step down.
Japan Times
COMMENTARY / World
Jun 28, 2023
Eli Lilly’s new weight-loss drug is even better than Ozempic
When it comes to manipulating the human metabolism, we’re entering entirely new territory with new drugs.
Japan Times
BUSINESS
Jun 1, 2023
Obesity and Alzheimer’s news makes Eli Lilly world’s most valuable drugmaker
An 8.5% gain in May for Eli Lilly lifted its shares to a record high, while displaced Johnson & Johnson slumped 5.3% during the month.
Japan Times
WORLD / Science & Health
May 5, 2023
Experimental Alzheimer’s drug slowed disease by 35% in trial, Eli Lilly reports
The results provide what experts say is the strongest evidence yet that removing sticky amyloid plaques from the brain benefits patients with the fatal disease.
Japan Times
WORLD / Science & Health
Nov 29, 2020
COVID-19 drugs from Lilly and Regeneron raise access and timing concerns
Powerful drugs recently authorized by the U.S. that may prevent those at the earliest stages of COVID-19 from suffering severe disease present thorny new challenges, including who will get them and where they’ll be administered.
Japan Times
BUSINESS / Companies
Jan 8, 2019
Eli Lilly makes $8 billion bet on drugs for rare cancers with Loxo Oncology buy
Eli Lilly said on Monday it will buy Loxo Oncology Inc. for $8 billion, an expensive bet on a pipeline of cancer drugs that target rare genetic mutations and the biggest acquisition in the drug-maker’s 143-year history.
Japan Times
JAPAN / Crime & Legal
Apr 2, 2015
Drugmaker Takeda may settle Actos suits for $2.2 billion
Officials at Asia’s largest drugmaker have proposed to settle more than 8,000 lawsuits in federal and state courts in the United States, according to sources who asked to remain anonymous.
Toyoko Kids: The lonely street children of Tokyo
Many young people who feel neglected at home flock to the Toyoko area to find a community where they can fit in.
Rising sex tourism exposes loopholes in 91AV原创 anti-prostitution law
While financial misfortunes during the COVID-19 pandemic may have driven some women to work the streets, others simply want more money to spend — or want to pay off their debts — at host clubs.
Japan unveils new overtourism countermeasures
The majority of tourists in Japan tend to stay in Tokyo, Osaka or Kyoto, resulting in overcrowding in popular tourist spots and a strain on transportation systems.
South Korea couple beat same-sex barriers to parenthood
South Korean lesbian couple Kim Kyu-jin (left) and her wife, Kim Sae-yeon, pose with a "pregnant woman" badge during an interview in Seoul last month.
Opportunities await the bold in the Year of the Wood Dragon
2024 marks the Year of the Dragon in the Chinese zodiac, with the year predicted to be a good time for fresh starts.
A dramatic bear hunt in a midsize Japanese city could be a harbinger of what is to come
Zookeeper Tetsuo Iso at the site of frantic search for a wild bear in Utsunomiya on June 9. Iso, 65, was asked by the prefectural government to help capture the bear and it was his shot with a tranquilizer gun that put an end to the saga.
How this long-term resident avoids the annoying tourist label in Japan
Tourists enjoy themselves while crossing the famous Shibuya Crossing in Tokyo on Oct. 12.
What can Asia do to avoid crossing crucial climate tipping points?
Motorists drive through a road covered with smog from wildfires nearby in Ogan Ilir in Indonesia's South Sumatra province on Sept. 25.
Baku championships showcase rising standards in global sumo
Ryan Roddy (second from left back) is pictured with the Ireland sumo team at this month's World Sumo Championships in Baku, Azerbaijan.
91AV原创 permanent residency reform has a glaring blind spot
Japan's immigration reforms risk creating uncertainty by tying permanent residency more closely to language proficiency before clear assessment standards and supporting infrastructure are in place.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Famima Park Azabudai is a concept store by FamilyMart that combines convenience store staples with branded apparel, merchandise and a landscaped outdoor space.
Convenience stores, toilets and the allure of everyday Japan
By Elizabeth Beattie

SUSTAINABLE JAPAN

SPECIAL SUPPLEMENTS note

SUPPLEMENTS BINDER